NCT07665034

Brief Summary

Background: Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contraction with minimal change in muscle length and joint angle. Most randomized trials of IRE are short duration and their long-term effects on BP and atherosclerotic complications, particularly in the Chinese, remain unknown. Study objectives: (i) To evaluate the impact of IRE on Clinic and Ambulatory BP (AMBP) in Hong Kong Chinese. (ii) To evaluate the impact of IRE on atherogeneisis surrogates (brachial flow-mediated dilation, FMD and carotid intima-media thickness IMT). (iii) To evaluate the impact of IRE on mechanisms of BP reduction, including endothelial function FMD, carotid IMT, inflammatory parameters and arterial wall stiffness (cfPWV). Setting: Randomized samples of 200 HT patients, aged 18-75 years with systolic BP 135-160mHg while on no or stable anti-HT medications. Design: Randomized controlled IRE trial - stratified randomization with randomization block size of 4.

  1. 1.100 patients for wall squat exercise of 14 mins each session (2 mins IRE x 4 sets, 2 mins rest in between), 3 sessions per week, for 1 year, plus advice on healthy diet and lifestyle.
  2. 2.100 control patients (usual care) with advice on diet and healthy lifestyles and simple stretching exercise programme (yoga) for 1 year.
  3. 3.BP - Clinic BP and Ambulatory BP parameters at baseline, 12 weeks and 24 weeks. (primary outcome)
  4. 4.Brachial FMD and carotid IMT at baseline, 24 weeks and 1 year. (primary outcome)
  5. 5.Carotid-femoral pulse wave velocity (cf-PWV) at baseline and 24 weeks.
  6. 6.Important atherosclerosis risk factor parameters at baseline, 24 weeks and 1 year - including fasting serum glucose, lipid profiles, HgbA1-C, creatinine, hs-CRP, CBP, fibrinogen, and interleukin 6 (IL-6).
  7. 7.Safety profiles (if any) including CVS event and hospitalization at 1 year.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Oct 2025Jul 2027

First Submitted

Initial submission to the registry

September 17, 2025

Completed
28 days until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2027

Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

September 17, 2025

Last Update Submit

June 23, 2026

Conditions

Keywords

Isometric Resistance ExerciseEssential HypertensionAtherosclerosisBrachial FMDCarotid IMTAtherosclerosis Prevention

Outcome Measures

Primary Outcomes (3)

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Daytime BP monitoring (mmHg)

    Baseline, 24 weeks and 1 year

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Brachial FMD (%)

    Baseline, 24 weeks and 1 year

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Carotid IMT (mm)

    Baseline, 24 weeks and 1 year

Secondary Outcomes (11)

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Baseline, 24 weeks and 1 year

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Baseline and 24 weeks

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Baseline, 24 weeks and 1 year

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Baseline, 24 weeks and 1 year

  • The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Baseline, 24 weeks and 1 year

  • +6 more secondary outcomes

Study Arms (2)

Anti HT + Isometric Resistance Squatting Exercise (100 Adults)

ACTIVE COMPARATOR

A more linear thigh-leg squatting angle is allowed in initial 2 weeks, but aiming at 90 degree thigh-leg angle after 4 weeks.

Other: Squatting Exercise

Anti HT + Stretching (Yoga) Exercise (100 Adults)

ACTIVE COMPARATOR

A liberal leg stretching excerise will be practised

Other: Stretching (Yoga) Exercise

Interventions

14 minutes per session (2 mins x 4 sets, 2 mins rest in between, 3 session per week)

Anti HT + Isometric Resistance Squatting Exercise (100 Adults)

2 mins x 4 sets, 2 mins rest in between, 3 sessions per week

Anti HT + Stretching (Yoga) Exercise (100 Adults)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • asymptomatic clinically stable adults
  • aged 18-75 years
  • Both genders
  • Suboptimal BP (on stable medication) with SBP 135-160mmHG on ambulatory BP monitoring (AMBP)
  • Agreeable to no drug changes in coming 1 year 24 weeks
  • Agreeable to provide informed written consent form
  • Agreeable to have AMBP and ultrasonic (FMD \& IMT) scan third (baseline, 24 weeks and preferably 1 year)

You may not qualify if:

  • relative contraindications to AMBP (e.g. atrial fibrillation)
  • severe osteoarthritis of knee
  • known secondary HT
  • pregnancy/breastfeeding
  • active malignancy
  • Serious coronary profiles, (unstable angina), renal or hepatic derangement
  • Need to change medications for control BP at 24 weeks ( SBP\>160 mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong, Department of Medicine & Therapeutics

Shatin, Hong Kong

RECRUITING

Related Publications (23)

  • Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043.

    PMID: 28097354BACKGROUND
  • Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.

    PMID: 24002282BACKGROUND
  • Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78. doi: 10.1161/CIR.0b013e3181dbece1. Epub 2010 May 10.

    PMID: 20458016BACKGROUND
  • Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3.

    PMID: 36056737BACKGROUND
  • Moncion K, Biasin L, Jagroop D, Bayley M, Danells C, Mansfield A, Salbach NM, Inness E, Tang A. Barriers and Facilitators to Aerobic Exercise Implementation in Stroke Rehabilitation: A Scoping Review. J Neurol Phys Ther. 2020 Jul;44(3):179-187. doi: 10.1097/NPT.0000000000000318.

    PMID: 32516297BACKGROUND
  • Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002 Apr 2;136(7):493-503. doi: 10.7326/0003-4819-136-7-200204020-00006.

    PMID: 11926784BACKGROUND
  • Smart NA, Gow J, Bleile B, Van der Touw T, Pearson MJ. An evidence-based analysis of managing hypertension with isometric resistance exercise-are the guidelines current? Hypertens Res. 2020 Apr;43(4):249-254. doi: 10.1038/s41440-019-0360-1. Epub 2019 Nov 22.

    PMID: 31758166BACKGROUND
  • Hansford HJ, Parmenter BJ, McLeod KA, Wewege MA, Smart NA, Schutte AE, Jones MD. The effectiveness and safety of isometric resistance training for adults with high blood pressure: a systematic review and meta-analysis. Hypertens Res. 2021 Nov;44(11):1373-1384. doi: 10.1038/s41440-021-00720-3. Epub 2021 Aug 12.

    PMID: 34385688BACKGROUND
  • Loaiza-Betancur AF, Chulvi-Medrano I. Is Low-Intensity Isometric Handgrip Exercise an Efficient Alternative in Lifestyle Blood Pressure Management? A Systematic Review. Sports Health. 2020 Sep/Oct;12(5):470-477. doi: 10.1177/1941738120943882. Epub 2020 Aug 10.

    PMID: 32776866BACKGROUND
  • Smart NA, Way D, Carlson D, Millar P, McGowan C, Swaine I, Baross A, Howden R, Ritti-Dias R, Wiles J, Cornelissen V, Gordon B, Taylor R, Bleile B. Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis. J Hypertens. 2019 Oct;37(10):1927-1938. doi: 10.1097/HJH.0000000000002105.

    PMID: 30889048BACKGROUND
  • Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7;340(8828):1111-5. doi: 10.1016/0140-6736(92)93147-f.

    PMID: 1359209BACKGROUND
  • Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000 Jul 15;86(2):207-10. doi: 10.1016/s0002-9149(00)00857-2. No abstract available.

    PMID: 10913483BACKGROUND
  • Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie MA, Morgan TM, Espeland MA. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001 Oct;8(5):319-28. doi: 10.1177/174182670100800512.

    PMID: 11702039BACKGROUND
  • Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003 May 21;41(10):1769-75. doi: 10.1016/s0735-1097(03)00333-4.

    PMID: 12767663BACKGROUND
  • Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1245-9. doi: 10.1161/01.atv.11.5.1245.

    PMID: 1911709BACKGROUND
  • Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997 Sep 2;96(5):1432-7. doi: 10.1161/01.cir.96.5.1432.

    PMID: 9315528BACKGROUND
  • O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999 Jan 7;340(1):14-22. doi: 10.1056/NEJM199901073400103.

    PMID: 9878640BACKGROUND
  • Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F; Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18(4):346-9. doi: 10.1159/000081812. Epub 2004 Nov 2.

    PMID: 15523176BACKGROUND
  • Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007 Jan 30;115(4):459-67. doi: 10.1161/CIRCULATIONAHA.106.628875. Epub 2007 Jan 22.

    PMID: 17242284BACKGROUND
  • Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS, Woo KS. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):739-43. doi: 10.1161/01.ATV.0000118015.26978.07. Epub 2004 Jan 22.

    PMID: 14739120BACKGROUND
  • Woo KS, Robinson JT, Chook P, Adams MR, Yip G, Mai ZJ, Lam CW, Sorensen KE, Deanfield JE, Celermajer DS. Differences in the effect of cigarette smoking on endothelial function in chinese and white adults. Ann Intern Med. 1997 Sep 1;127(5):372-5. doi: 10.7326/0003-4819-127-5-199709010-00006.

    PMID: 9273828BACKGROUND
  • Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2487-93. doi: 10.1161/01.atv.19.10.2487.

    PMID: 10521379BACKGROUND
  • (24) Woo KS, Chook P, Hu YJ, Wong MK, Yin YH, Li Albert Martin, Chan SW, Kwok CY Timothy and Celermajer DS. Age and Gender Specific Reference Values of Brachial Flow-mediated Dilation and Carotid Intima-media Thickness in CATHAY Study: Atherosclerosis Surrogate Markers in Chinese Adults. J Cardio and Vasc Med 2023;9:103.

    BACKGROUND

MeSH Terms

Conditions

Essential HypertensionAtherosclerosis

Interventions

YogaExercise

Condition Hierarchy (Ancestors)

HypertensionVascular DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy ModalitiesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kam Sang Woo

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

KS Woo, MBBS, MD, FACC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor

Study Record Dates

First Submitted

September 17, 2025

First Posted

June 24, 2026

Study Start

October 15, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

July 30, 2027

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

There is a plan to make IPD and related data dictionaries available. All IPD that underline results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till July 2027
Access Criteria
These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till July 2027 (kamsangwoo@cuhk.edu.hk/ crec@cuhk.edu.hk)

Locations